Tag Archives: Trial

Soligenix Inc (OTCBB:SNGX) Completes Enrollment Into Phase II Clinical Trial … – StocksnTrade (registration) (blog)

StocksnTrade (registration) (blog) Soligenix Inc (OTCBB:SNGX) Completes Enrollment Into Phase II Clinical Trial …StocksnTrade (registration) (blog)A couple of weeks ago, Soligenix Inc (OTCBB:SNGX) reported that it completed patient enrollment as suggested by the Data Review Committee earlier in 2015, into … Continue reading

Posted in OTCBB | Tagged , , , , , , , , , , | Comments Off on Soligenix Inc (OTCBB:SNGX) Completes Enrollment Into Phase II Clinical Trial … – StocksnTrade (registration) (blog)

Cavitation Technologies Receives Nano Reactor® System Trial for Canada

Cavitation announces new system trial agreement with a canola oil refinery in Canada. (PRWeb March 20, 2015) Read the full story at http://www.prweb.com/releases/2015/03/prweb12596923.htm OTCBB from Google and yahoo

Posted in OTCBB | Tagged , , , , , , , | Comments Off on Cavitation Technologies Receives Nano Reactor® System Trial for Canada

Burzynski Research Institute, Inc. Announces FDA Permission to Launch a New Clinical Trial in Diffuse Intrinsic …

HOUSTON, Oct. 24, 2014 /PRNewswire/ — Burzynski Research Institute, Inc. (BRI) announced today that the U.S. Food and Drug Administration (FDA) has given the company permission to conduct an open-label study of Antineoplastons A10 and AS2-1 in patients > 3 … Continue reading

Posted in OTCBB | Tagged , , , , , , , , , , | Comments Off on Burzynski Research Institute, Inc. Announces FDA Permission to Launch a New Clinical Trial in Diffuse Intrinsic …

Day-Swing Trading Live Educational Trading Chat Room for Stock Market and Option Traders- Now Offering Free 2-Week Trial

New York, NY (PRWEB) May 04, 2012 Equity Trading Capital’s Day Trading Chat Room offers an array of opportunities for new and existing traders. Whether you are an intense, minute by minute trader or a longer term swing trader, you … Continue reading

Posted in Stock Market Investing | Tagged , , , , , , , , , , , , , | Comments Off on Day-Swing Trading Live Educational Trading Chat Room for Stock Market and Option Traders- Now Offering Free 2-Week Trial

QualityStocks News – InspireMD Announces Positive Results from MASTER MGuard Stent Trial

Scottsdale, Arizona (PRWEB) August 21, 2012 QualityStocks would like to highlight InspireMD Inc., a medical device company, focused on the development and commercialization of proprietary MGuard stent platform technology with applications in interventional cardiology and other vascular procedures. Its lead … Continue reading

Posted in Stock Market Investing | Tagged , , , , , , , , , , | Comments Off on QualityStocks News – InspireMD Announces Positive Results from MASTER MGuard Stent Trial

GENSPERA INC : GenSpera Obtains Authorization for G-202 Phase II Trial in the … – 4-traders

GENSPERA INC : GenSpera Obtains Authorization for G-202 Phase II Trial in the …4-tradersGenSpera, Inc. (OTCBB:GNSZ) announced that the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom (UK) has cleared for initiation a Phase II human clinical … Continue reading

Posted in OTCBB | Tagged , , , , , , | Comments Off on GENSPERA INC : GenSpera Obtains Authorization for G-202 Phase II Trial in the … – 4-traders

NAT completes 100-ton CRAiLAR Flax Fiber pre-production trial at Barnhardt Manufacturing

VICTORIA, BC and PORTLAND, OR, Aug. 16, 2012 /PRNewswire/ – Naturally Advanced Technologies Inc. ("NAT" or the "Company") (TSXV: NAT) (OTCBB: NADVF), which produces and markets CRAiLAR® Flax Fiber, announced it had completed its final large scale production and commercialization… … Continue reading

Posted in OTCBB | Tagged , , , , , , , , | Comments Off on NAT completes 100-ton CRAiLAR Flax Fiber pre-production trial at Barnhardt Manufacturing

QualityStocks News – Access Pharmaceuticals Presents Positive Data of MuGard Phase 4 Clinical Trial at Cancer Symposium

Scottsdale, AZ (PRWEB) June 29, 2012 QualityStocks would like to highlight Access Pharmaceuticals, Inc., a publicly traded biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients. The company’s products include MuGard, which … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , | Comments Off on QualityStocks News – Access Pharmaceuticals Presents Positive Data of MuGard Phase 4 Clinical Trial at Cancer Symposium

QualityStocks News – Northwest Biotherapeutics Receives $5.5M Grant to Cover Manufacturing and Clinical Trial Costs

Scottsdale, Arizona (PRWEB) May 02, 2012 QualityStocks would like to highlight Northwest Biotherapeutics, Inc., a publicly traded biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , | Comments Off on QualityStocks News – Northwest Biotherapeutics Receives $5.5M Grant to Cover Manufacturing and Clinical Trial Costs

Proteonomix provides corporate and clinical trial updates

Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today provided updates on its progress. OTCBB from Google and yahoo

Posted in OTCBB | Tagged , , , , , | Comments Off on Proteonomix provides corporate and clinical trial updates

QualityStocks News – PLC Systems Treats First Patient in RenalGuard

Scottsdale, AZ (PRWEB) January 23, 2012 QualityStocks would like to highlight PLC Systems, Inc., a publicly traded company. Headquartered in Milford, Mass., PLC is a medical device company focused on innovative technologies for the cardiac and vascular markets. PLC’s newest … Continue reading

Posted in Stock Market Investing | Tagged , , , , , , , , | Comments Off on QualityStocks News – PLC Systems Treats First Patient in RenalGuard